Can We Identify Patients in Danger of Delayed Treatment? Management of COVID-19 Pandemic Backlog in Urology Care in Poland
- PMID: 36554427
- PMCID: PMC9779168
- DOI: 10.3390/ijerph192416547
Can We Identify Patients in Danger of Delayed Treatment? Management of COVID-19 Pandemic Backlog in Urology Care in Poland
Abstract
The COVID-19 pandemic had a tremendous impact on healthcare systems around the world. This study aims to research the course of surgical treatment in urology during the pandemic in 2020, evaluate the volume of deferred treatment in urology in Poland, and indicate groups of patients that are especially vulnerable to a delay in the delivery of healthcare services. The National Health Found statistics (NHF) database was searched for information on procedures completed in urology departments from 2015 to 2020. Changes in hospital discharges of adults from 2019 to 2021 were investigated using monthly reports of NHF on patient billing groups. Statistics of PSA, testosterone, and creatinine testing were extracted from NHF reports. Annual changes in the number of surgeries were calculated. Then, the estimation of the expected quantity of procedures without the occurrence of the pandemic was performed using linear regression based on data from 2015 to 2020. The estimation was assumed reliable at R2 > 0.8. The difference between collected and estimated data was analysed. In 2020, the volume of radical prostatectomies, cystectomies, and kidney surgeries noted downturns following lockdowns in March and November. All analysed procedures, except radical cystectomy, noted a reduction in the entire year. The declines reached -34% in shockwave lithotripsy, -13% in ureterorenoscopic lithotripsy, -22% in cystolithotripsy, -28% in percutaneous lithotripsy, -12% in transurethral resection of a bladder tumour (TURBT), -31% in transurethral resection of the prostate, -15% in nephrectomy and kidney tumorectomy, and -10% in radical prostatectomy. Among the analysed procedures, only radical cystectomy rates increased 5%. Prostate-specific antigen and creatinine tests fell -17%, and testosterone testing was down -18%. In conclusion, the patients most vulnerable to delayed treatment due to the post-pandemic backlog are those requiring TURBT, kidney cancer operations, and radical prostatectomies. Solving backlogs in urology should prioritise cancer patients and thus requires improved access to cystoscopy, TURBT, diagnoses and surgery of prostate and kidney tumours. Addressing the needs of patients suffering from benign diseases demands appropriate measures to increase the surgical productivity of urology departments.
Keywords: COVID-19; backlog; oncology; urolithiasis; urology.
Conflict of interest statement
The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.
Figures






Similar articles
-
Consequences of SARS-CoV-2 pandemic on urological surgery in France: a nationwide analysis of the healthcare system database.BMJ Open. 2022 Nov 14;12(11):e066220. doi: 10.1136/bmjopen-2022-066220. BMJ Open. 2022. PMID: 36375970 Free PMC article.
-
Changes in Urologic Cancer Surgical Volume and Length of Stay During the COVID-19 Pandemic in Pennsylvania.JAMA Netw Open. 2023 Apr 3;6(4):e239848. doi: 10.1001/jamanetworkopen.2023.9848. JAMA Netw Open. 2023. PMID: 37097635 Free PMC article.
-
Forecasting the Future of Urology Practice: A Comprehensive Review of the Recommendations by International and European Associations on Priority Procedures During the COVID-19 Pandemic.Eur Urol Focus. 2020 Sep 15;6(5):1032-1048. doi: 10.1016/j.euf.2020.05.007. Epub 2020 May 31. Eur Urol Focus. 2020. PMID: 32553544 Free PMC article. Review.
-
The impact of COVID-19 on surgical volume and surgical training at a high-volume pelvic oncology centre.Urologia. 2022 Nov;89(4):495-499. doi: 10.1177/03915603211062827. Epub 2021 Dec 8. Urologia. 2022. PMID: 34877900
-
Management of patients who opt for radical prostatectomy during the coronavirus disease 2019 (COVID-19) pandemic: an international accelerated consensus statement.BJU Int. 2021 Jun;127(6):729-741. doi: 10.1111/bju.15299. Epub 2021 Mar 10. BJU Int. 2021. PMID: 33185026
Cited by
-
Epidemiological characteristics of 214,063 hospital admissions to adult urological departments in Poland in 2022.Cent European J Urol. 2024;77(3):538-546. doi: 10.5173/ceju.2024.55.R1. Epub 2024 Jun 18. Cent European J Urol. 2024. PMID: 40115477 Free PMC article.
-
The COVID-19 pandemic and Urology - reflecting on successful initiatives and lessons in Australia.BJU Int. 2025 Apr;135 Suppl 3(Suppl 3):5-11. doi: 10.1111/bju.16652. Epub 2025 Jan 19. BJU Int. 2025. PMID: 39829160 Free PMC article. Review.
-
Did the COVID-19 Pandemic Restrict Access to Emergency Urological Services: Assessment of Reorganisation Effectiveness for Hospital Treatment.Int J Environ Res Public Health. 2023 Feb 20;20(4):3735. doi: 10.3390/ijerph20043735. Int J Environ Res Public Health. 2023. PMID: 36834430 Free PMC article.
References
-
- Zeidler A., Karpiński T.M. What Do We Know about SARS-CoV-2 Virus and COVID-19 Disease? J. Pre-Clin. Clin. Res. 2020;14:33–38. doi: 10.26444/jpccr/123794. - DOI
-
- Raport Zakażeń Koronawirusem (SARS-CoV-2)—Koronawirus: Informacje I Zalecenia—Portal Gov.pl. [(accessed on 5 November 2022)];(In Polish) Available online: https://www.gov.pl/web/koronawirus/wykaz-zarazen-koronawirusem-sars-cov-2.
-
- Wang H., Paulson K.R., A Pease S., Watson S., Comfort H., Zheng P., Aravkin A.Y., Bisignano C., Barber R.M., Alam T., et al. Estimating Excess Mortality due to the COVID-19 Pandemic: A Systematic Analysis of COVID-19-Related Mortality, 2020–21. Lancet. 2022;399:1513–1536. doi: 10.1016/S0140-6736(21)02796-3. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous